Skip to main content
OpenTrials

Clinical trial condition

Neoplasms

Explore clinical trials studying Neoplasms. Study availability and eligibility vary by location and protocol.

8,001 public trials 1,520 recruiting studies
Refine in advanced search Browse all conditions

Neoplasms trial results

Completed

JTX-2011 Alone and in Combination With Anti-PD-1 or Anti-CTLA-4 in Subjects With Advanced and/or Refractory Solid Tumors

NCT02904226

Conditions
Cancer, Neoplasms
Locations
  • Stanford University School of Medicine Palo Alto, California, United States
  • Sarah Cannon Research Institute at HealthONE Denver, Colorado, United States
  • Yale New Haven Hospital New Haven, Connecticut, United States
  • Georgetown Lombardi Comprehensive Cancer Center Washington D.C., District of Columbia, United States
View all 16 locations
View Trial Details
Completed

S1204, Viral Screening in Newly Diagnosed Cancer Patients

NCT01946516

Conditions
Cancer, Neoplasms
Locations
  • Kaiser Permanente Hospital Fontana, California, United States
  • Kaiser Permanente - Harbor City Harbor City, California, United States
  • Contra Costa Regional Medical Center Martinez, California, United States
  • East Bay Physicians Medical Group-Summit Oakland, California, United States
View all 58 locations
View Trial Details
Completed

Study of a PD-1 Inhibitor (JTX-4014) in Subjects With Solid Tumor Malignancies

NCT03790488

Conditions
Cancer, Neoplasms
Locations
  • Sarah Cannon Research Institute at HealthONE Denver, Colorado, United States
  • Florida Cancer Specialists - Sarasota Cattlemen Sarasota, Florida, United States
  • START Midwest - Cancer & Hematology Centers of Western Michigan Grand Rapids, Michigan, United States
  • South Texas Accelerated Research Therapeutics (START) San Antonio, Texas, United States
View Trial Details
Completed

Axitinib Given on an Individualized Schedule for Metastatic Renal Cell Cancer

NCT02579811

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center Cleveland, Ohio, United States
  • The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute Columbus, Ohio, United States
  • Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States
View Trial Details
Completed

Delanzomib (CEP-18770) in Combination With Lenalidomide and Dexamethasone in Relapsed or Refractory Multiple Myeloma

NCT01348919

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Teva Investigational Site 1 Augusta, Georgia, United States
  • Teva Investigational Site 3 Lexington, Kentucky, United States
  • Teva Investigational Site 2 Houston, Texas, United States
  • Teva Investigational Site 201 Auckland, New Zealand
View Trial Details
Completed

Nab-paclitaxel and Gemcitabine vs Gemcitabine Alone as Adjuvant Therapy for Patients With Resected Pancreatic Cancer (the "Apact" Study)

NCT01964430

Conditions
Adenocarcinoma, Antimetabolites, Antineoplastic, Carcinoma, +11 more
Locations
  • Local Institution - 043 Scottsdale, Arizona, United States
  • Mayo Clinic - Arizona Scottsdale, Arizona, United States
  • UCSD Moores Cancer Center La Jolla, California, United States
  • University of Southern California Los Angeles, California, United States
View all 341 locations
View Trial Details

Related conditions